-
Bellerophon Prices $7M Public Offering
Post on 1/23/19
-
Pfizer Looks To Move Tafamidis Forward With Priority Review
Post on 1/23/19
-
Johnson & Johnson (JNJ) Q4 2018 Earnings Conference Call Transcript
Post on 1/23/19
-
Pfizer: Still A Cash Cow
Post on 1/23/19
-
Better Buy: Pfizer vs. AbbVie
Post on 1/23/19
-
Slowing Growth Worries Johnson & Johnson Shareholders
Post on 1/23/19
-
PTC Therapeutics Proposes Public Offering of Common Stock
Post on 1/22/19
-
Bellerophon Therapeutics Proposes Public Offering of Common Stock
Post on 1/22/19
-
Johnson & Johnson Reports 2018 Fourth-Quarter Results
Post on 1/22/19
-
Bristol-Myers/Celgene: The Spread Is Your Friend
Post on 1/22/19
-
Would Pfizer Shareholders Win With an Acquisition of Amarin?
Post on 1/22/19
-
Better Buy: AbbVie vs. Johnson & Johnson
Post on 1/22/19
-
Xybion Partners with Northwell Health
Post on 1/21/19
-
This Penn Spinout Is Starting Off The Year With A New License Deal And Seed Funding
Post on 1/21/19
-
Cooper University Health Care First Hospital Site in the Nation
Post on 1/18/19
-
Celgene: Great Opportunities For Option Investors
Post on 1/18/19
-
Parker Awards a $2.5M Grant to VNA Health Group
Post on 1/17/19
-
Johnson & Johnson: P/E Matters
Post on 1/17/19
-
Amarin: Evaluating The Merits Of A Potential Pfizer Acquisition
Post on 1/17/19
-
Is Pfizer a Buy?
Post on 1/17/19
-
Bucci Laser Vision Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts
Post on 1/16/19
-
Bristol-Myers Squibb Stock Issued For Celgene: I Plan To Keep It
Post on 1/16/19
-
Krystal Biotech Completes Construction of Ancoris - A New GMP Facility
Post on 1/15/19
-
QPharma Welcomes New Clients, Celebrates 25-Year Anniversary
Post on 1/15/19
-
Is Teva Pharmaceutical Industries Limited Stock a Bargain?
Post on 1/15/19